Dr Lalchandani Labs Limited (BOM:541299)
India · Delayed Price · Currency is INR 7.77
+0.01 (0.13%)
At close: Jul 31, 2026
Dr Lalchandani Labs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 67 | 128 | 44 | 68 | 123 | 143 | |
Market Cap Growth | -24.74% | 188.85% | -34.95% | -44.70% | -13.91% | 137.41% |
Enterprise Value | 46 | 139 | 52 | 107 | 157 | 144 |
Last Close Price | 7.77 | 14.81 | 7.55 | 11.61 | 21.00 | 24.39 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 111.00 | 201.44 | 10.62 | 11.02 | - | 15.32 |
PS Ratio | 1.60 | 3.06 | 0.99 | 1.42 | 2.44 | 1.27 |
PB Ratio | 0.47 | 0.91 | 0.45 | 0.71 | 1.38 | 1.36 |
P/TBV Ratio | 0.48 | 0.92 | 0.46 | 0.74 | 1.44 | 1.42 |
P/FCF Ratio | - | - | 20.85 | - | - | 15.71 |
P/OCF Ratio | - | - | 12.06 | - | 10258.54 | 7.13 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.11 | 3.31 | 1.18 | 2.22 | 3.11 | 1.28 |
EV/EBITDA Ratio | 64.99 | 194.43 | 5.96 | 45.98 | 173.33 | 5.84 |
EV/EBIT Ratio | - | - | 14.54 | - | - | 7.66 |
EV/FCF Ratio | - | - | 24.66 | - | - | 15.85 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.15 | 0.15 | 0.41 | 0.37 | 0.72 | 0.49 |
Debt / EBITDA Ratio | 28.95 | 28.95 | 4.63 | 14.95 | 70.77 | 2.08 |
Debt / FCF Ratio | - | - | 19.15 | - | - | 5.65 |
Net Debt / Equity Ratio | -0.15 | -0.15 | 0.08 | 0.12 | 0.36 | 0.15 |
Net Debt / EBITDA Ratio | -29.13 | -29.13 | 0.88 | 5.10 | 35.28 | 0.65 |
Net Debt / FCF Ratio | 1.90 | 1.90 | 3.62 | -3.56 | -10.51 | 1.77 |
Asset Turnover | 0.25 | 0.25 | 0.29 | 0.29 | 0.28 | 0.68 |
Inventory Turnover | 1.83 | 1.83 | 1.33 | 2.12 | 1.76 | 4.14 |
Quick Ratio | 3.04 | 3.04 | 1.54 | 1.42 | 1.56 | 1.59 |
Current Ratio | 3.79 | 3.79 | 1.92 | 1.89 | 2.07 | 2.22 |
Return on Equity (ROE) | 0.53% | 0.53% | 4.28% | 6.69% | -16.11% | 9.32% |
Return on Assets (ROA) | -1.86% | -1.86% | 1.47% | -1.50% | -2.00% | 7.07% |
Return on Invested Capital (ROIC) | -2.68% | -2.84% | 3.36% | -3.43% | -4.73% | 11.99% |
Return on Capital Employed (ROCE) | -3.50% | -3.50% | 3.60% | -3.90% | -4.60% | 14.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.95% | 0.50% | 9.42% | 9.07% | -12.70% | 6.53% |
FCF Yield | -16.31% | -8.56% | 4.80% | -4.89% | -2.47% | 6.37% |
Buyback Yield / Dilution | -108.74% | -108.74% | -0.64% | 0.25% | 0.27% | -0.01% |